SCHEMBL4099862

SCHEMBL4099862

CCCCCC=CCC=CCC=CCC=CCCCC(=O)Oc1cc(O)cc(C=Cc2ccc(O)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.50
ALDH1A1 P00352 5/20 0.50
MAPT P10636 5/20 0.50
CNR2 P34972 4/20 0.50
HPGD P15428 4/20 0.50
PSMB11 A5LHX3 2/20 0.50
MEN1 O00255 2/20 0.50
PSMA7 O14818 2/20 0.50
TP53 P04637 2/20 0.50
CYP3A4 P08684 2/20 0.50
ALOX15 P16050 2/20 0.50
PSMB1 P20618 2/20 0.50
PSMA1 P25786 2/20 0.50
PSMA2 P25787 2/20 0.50
PSMA3 P25788 2/20 0.50
PSMA4 P25789 2/20 0.50
PSMB8 P28062 2/20 0.50
PSMB9 P28065 2/20 0.50
PSMA5 P28066 2/20 0.50
PSMB4 P28070 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2513369 0.97 PSMB11 (0.47) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL4096611 0.97 MAPT (0.51) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL4097199 0.96 MGLL (0.45) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL2519715 0.94 PSMB11 (0.49) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL4092190 0.94 PSMB11 (0.49) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL2518028 0.93 PSMB11 (0.48) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL2515292 0.92 ALB (0.45) ALDH1A1MAPTHPGDMEN1TP53
SCHEMBL4103844 0.91 MGLL (0.47) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL2514397 0.91 PSMB11 (0.50) CNR1ALDH1A1MAPTCNR2HPGD
SCHEMBL4097267 0.91 PSMB11 (0.50) CNR1ALDH1A1MAPTCNR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 CNR1 3589/4885ALDH1A1 3004/4885MAPT 2543/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA CNR1 4431/4885ALDH1A1 2613/4885MAPT 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.